Thomas John, Thomas George, Chatim Ajay, Shukla Param, Mardiney Matthew
N/A, West Virginia School of Osteopathic Medicine, Lewisburg, USA.
N/A, George Washington University School of Medicine and Health Sciences, Washington, USA.
Cureus. 2021 Sep 19;13(9):e18102. doi: 10.7759/cureus.18102. eCollection 2021 Sep.
Public health efforts over the past few months have been aimed at vaccinating young adults. Moderna and Pfizer COVID-19 vaccines are widely available options. Cutaneous reactions to these vaccines have been described as self-limiting and relatively immediate after vaccine administration. In this case report, we present a young adult who received the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine and developed chronic, spontaneous urticaria.
过去几个月里,公共卫生工作一直致力于为年轻人接种疫苗。莫德纳和辉瑞的新冠疫苗是广泛可用的选择。这些疫苗的皮肤反应被描述为自限性的,且在接种疫苗后相对迅速出现。在本病例报告中,我们介绍了一名接种辉瑞-BioNTech BNT162b2 mRNA新冠疫苗后出现慢性自发性荨麻疹的年轻人。